2023
Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology
Mortlock R, Ma E, Cohen J, Damsky W. Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology. Journal Of Investigative Dermatology 2023, 143: 1412-1422. PMID: 37341663, PMCID: PMC10830170, DOI: 10.1016/j.jid.2023.04.005.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAtopic dermatitisSkin diseasesInflammatory skin diseaseInflammatory skin conditionImmunologic biomarkersImmune biomarkersPersonalized medicineInflammatory dermatosesImmunologic approachesTherapy selectionSkin conditionsSingle-cell RNA sequencingMolecular profilingBiomarkersTissue stainingPsoriasisDermatitisDiseaseDermatologyRNA sequencingMedicineCurettageDermatosesTherapyPersonalized classification
2022
The association of anxiety with granuloma annulare: a case–control study of the National Institutes of Health ‘All of Us’ research programme
Belzer A, Leasure A, Damsky W, Cohen J. The association of anxiety with granuloma annulare: a case–control study of the National Institutes of Health ‘All of Us’ research programme. British Journal Of Dermatology 2022, 188: 558-560. PMID: 36715356, DOI: 10.1093/bjd/ljac114.Peer-Reviewed Original ResearchConceptsCase-control studyGranuloma annulareMental health conditionsInflammatory dermatosesHealth conditionsInflammatory skin diseaseImprovement of depressionAssociation of anxietyPost-traumatic stress disorderOpioid dependenceAutoimmune disordersProinflammatory cytokinesBody of evidenceDear EditorSkin diseasesSignificant associationDermatosesStress disorderNational InstituteAnnulareAssociationDisordersDepressionAnxietyDyslipidaemia
2019
The color of skin: purple diseases of the skin, nails, and mucosa
Steuer AB, Cohen JM. The color of skin: purple diseases of the skin, nails, and mucosa. Clinics In Dermatology 2019, 37: 528-547. PMID: 31896408, DOI: 10.1016/j.clindermatol.2019.07.016.Peer-Reviewed Original ResearchMeSH KeywordsAnticoagulantsAntiphospholipid SyndromeCalciphylaxisChurg-Strauss SyndromeColorCryoglobulinemiaDiagnosis, DifferentialGranulomatosis with PolyangiitisHumansLevamisoleMicroscopic PolyangiitisNecrosisPolyarteritis NodosaPurpura FulminansPurpura, Thrombotic ThrombocytopenicSkinVasculitisWarfarinConceptsCutaneous vasculitisCutaneous small vessel vasculitisLevamisole-induced vasculopathyAntiphospholipid antibody syndromeSmall vessel vasculitisThrombotic thrombocytopenic purpuraAntibody syndromeEosinophilic granulomatosisPolyarteritis nodosumEcthyma gangrenosumMicroscopic polyangiitisSkin necrosisInfectious dermatosesLichen planusPurpura fulminansThrombocytopenic purpuraInflammatory dermatosesSystemic diseaseClinical appearanceKaposi's sarcomaVasculitisPolyangiitisGranulomatosisVasculopathyDermatoses
2017
Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis
Weng QY, Raff AB, Cohen JM, Gunasekera N, Okhovat JP, Vedak P, Joyce C, Kroshinsky D, Mostaghimi A. Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis. JAMA Dermatology 2017, 153: 141-146. PMID: 27806170, DOI: 10.1001/jamadermatol.2016.3816.Peer-Reviewed Original ResearchLower extremity cellulitisExtremity cellulitisMedical Expenditure Panel SurveyEmergency departmentHospital courseUnnecessary antibioticsHealth care spendingDays of dischargeTreatment of cellulitisDiagnosis of cellulitisHealth care burdenNational health care burdenClostridium difficile infectionCases of anaphylaxisUnnecessary patient morbidityCare spendingCross-sectional studyLarge urban hospitalComplication ratePatient characteristicsHospitalization costsInflammatory dermatosesPatient morbidityDifficile infectionAlternative diagnoses